Acquisitions, Mergers & PartnershipsBioprintingMedical

FluidForm to develop new 3D bioprinting solutions for J&J

Collaboration with Ethicon to expand and utilize FRESH 3D bioprinting technology across a variety of applications

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.

FluidForm has signed an agreement with Ethicon “Ethicon is a global leader in surgery”, Mike Graffeo, FluidForm’s CEO said, “and their 3D Printing Center is a leader in the industry when it comes to applications of 3D printing in medicine. We are thrilled by the impact that FRESH printing can have and are excited to collaborate with Ethicon to deliver on these ambitious goals”.

The ability to recreate functional human tissue for research, training and potential replacement has the potential to transform human health. FRESH printing is a technology that has been proven to recreate biology, from structure to function. FluidForm seeks to deliver on the promise of tissue therapies, in order to radically transform human health and longevity.

According to FluidForm there are about 130,000 people on the nation’s organ transplant waiting list, but the need for organs is actually about 10 times that size. Graffeo said he wants FluidForm’s technology to get to a point where it’s readily available in hospitals.

“Compare it to a company like SpaceX that wants to get to Mars. But in order to get to Mars, they had to start by putting satellites into orbit, and then by taking astronauts to the space station. They first reached the moon, and then they finally got to Mars. Those building blocks had to be there,” Graffeo said to Boston area online publication BostonInno.

The company is still working on its sales and distribution model, depending on when the company is able to develop full-term tissue and organs and how it will get its products into hospitals.

“Some of those products that we develop would be best sold by us, some of those products we develop might be best sold by a partner,” Graffeo said.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Andrea Gambini

Andrea has always loved reading and writing. He started working in an editorial office as a sports journalist in 2008, then the passion for journalism and for the world of communication in general, allowed him to greatly expand his interests, leading to several years of collaborations with several popular online newspapers. Andrea then approached 3D printing, impressed by the great potential of this new technology, which day after the day pushed him to learn more and more about what he considers a real revolution that will soon be felt in many fields of our daily life.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!